171 related articles for article (PubMed ID: 32994701)
21. Should We Completely Exclude Locoregional Therapy for the Primary Tumor from Our Clinical Practice in De Novo Metastatic Breast Cancer?
Kus T; Aktas G
Ann Surg Oncol; 2022 Sep; 29(9):5359-5360. PubMed ID: 35661954
[TBL] [Abstract][Full Text] [Related]
22. Clinical information and management status of de novo stage IV breast cancer patients: a Chinese multicenter investigation (CSBrS-002).
Zheng A; Guo BL; Zhang JG; Jin F;
Chin Med J (Engl); 2021 Jun; 134(13):1569-1575. PubMed ID: 34101635
[TBL] [Abstract][Full Text] [Related]
23. Role of Operative Management in Stage IV Breast Cancer.
Teshome M
Surg Clin North Am; 2018 Aug; 98(4):859-868. PubMed ID: 30005779
[TBL] [Abstract][Full Text] [Related]
24. Locoregional Treatments for Metastatic Gastrointestinal Stromal Tumor in British Columbia: A Retrospective Cohort Study from January 2008 to December 2017.
Patterson T; Li H; Chai J; Debruyns A; Simmons C; Hart J; Pollock P; Holloway CL; Truong PT; Feng X
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326632
[TBL] [Abstract][Full Text] [Related]
25. Survival Implications of De Novo Versus Recurrent Metastatic Non-Small Cell Lung Cancer.
Moore S; Leung B; Wu J; Ho C
Am J Clin Oncol; 2019 Mar; 42(3):292-297. PubMed ID: 30608237
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value and mode selection of locoregional treatment in Stage-IV breast cancer patients.
Cui H; Ren X; Zhao X; Dai L; Liu D; Bao Y; Hu L; Xiao Z; Ma X; Kang H
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13591-13605. PubMed ID: 37515611
[TBL] [Abstract][Full Text] [Related]
27. Aggressive local therapy for
Liu B; Liu H; Liu M
Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37449542
[TBL] [Abstract][Full Text] [Related]
28. Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis.
Pons-Tostivint E; Kirova Y; Lusque A; Campone M; Geffrelot J; Mazouni C; Mailliez A; Pasquier D; Madranges N; Firmin N; Crouzet A; Gonçalves A; Jankowski C; De La Motte Rouge T; Pouget N; de La Lande B; Mouttet-Boizat D; Ferrero JM; Uwer L; Eymard JC; Mouret-Reynier MA; Petit T; Robain M; Filleron T; Cailliot C; Dalenc F
Ann Surg Oncol; 2019 Feb; 26(2):356-365. PubMed ID: 30539492
[TBL] [Abstract][Full Text] [Related]
29. Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of Life.
Si Y; Yuan P; Hu N; Wang X; Ju J; Wang J; Ma F; Luo Y; Zhang P; Li Q; Xu B
Ann Surg Oncol; 2020 Apr; 27(4):1025-1033. PubMed ID: 31970572
[TBL] [Abstract][Full Text] [Related]
30. Additional radiotherapy to breast-conserving surgery is an optional treatment for de novo stage IV breast cancer: A population-based analysis.
Wang J; Yang SP; Zhou P; Lian CL; Lei J; Hua L; He ZY; Wu SG
Cancer Med; 2021 Mar; 10(5):1634-1643. PubMed ID: 33586323
[TBL] [Abstract][Full Text] [Related]
31. Metastatic breast cancers: Estimates for Italy.
Crocetti E; Gori S; Falcini F
Tumori; 2018; 104(2):116-120. PubMed ID: 29714648
[TBL] [Abstract][Full Text] [Related]
32. Effect of local surgery on outcomes of stage IV breast cancer.
Tsukioki T; Shien T; Doihara H
Transl Cancer Res; 2020 Aug; 9(8):5102-5107. PubMed ID: 35117876
[TBL] [Abstract][Full Text] [Related]
33. Primary tumor resection in de novo stage IV breast cancer patients.
Follette CJ; Humphrey C; Amin A; Balanoff C; Wagner J; Larson K
Breast J; 2020 Jul; 26(7):1366-1369. PubMed ID: 32337754
[TBL] [Abstract][Full Text] [Related]
34. Is there a role for locoregional treatment of the primary tumor in de novo metastatic breast cancer in the era of tailored therapies?: Evidences, unresolved questions and a practical algorithm.
Pons-Tostivint E; Alouani E; Kirova Y; Dalenc F; Vaysse C
Crit Rev Oncol Hematol; 2021 Jan; 157():103146. PubMed ID: 33227574
[TBL] [Abstract][Full Text] [Related]
35. Survival differences among women with de novo stage IV and relapsed breast cancer.
Dawood S; Broglio K; Ensor J; Hortobagyi GN; Giordano SH
Ann Oncol; 2010 Nov; 21(11):2169-2174. PubMed ID: 20427349
[TBL] [Abstract][Full Text] [Related]
36. Brain metastasis in de novo stage IV breast cancer.
He Y; Shao Y; Chen Q; Liu C; Zhu F; Liu H
Breast; 2023 Oct; 71():54-59. PubMed ID: 37499376
[TBL] [Abstract][Full Text] [Related]
37. The Difference in Prognostic Outcomes Between
Yamamura J; Kamigaki S; Fujita J; Osato H; Komoike Y
In Vivo; 2018; 32(2):353-358. PubMed ID: 29475920
[TBL] [Abstract][Full Text] [Related]
38. The Role of Primary Surgery in
Demirors B; Goktepe B; Medeck H; Ozbas S; Soran A
Eur J Breast Health; 2023 Apr; 19(2):110-114. PubMed ID: 37025581
[TBL] [Abstract][Full Text] [Related]
39. Clinical Evidence for Locoregional Surgery of the Primary Tumor in Patients with De Novo Stage IV Breast Cancer.
Yu Y; Hong H; Wang Y; Fu T; Chen Y; Zhao J; Chen P; Cai R; Tan Y; He Z; Ren W; Zhou L; Huang J; Tang J; Ye G; Yao H
Ann Surg Oncol; 2021 Sep; 28(9):5059-5070. PubMed ID: 33534046
[TBL] [Abstract][Full Text] [Related]
40. Locoregional Therapy in De novo Metastatic Breast Cancer: A Retrospective Cohort Study.
Jianna S; Lingjun K; Nana F; Hong L; Chongxi R
Technol Cancer Res Treat; 2022; 21():15330338221115356. PubMed ID: 35899318
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
